Literature DB >> 9544832

A case of malignant peritoneal mesothelioma showed complete remission with chemotherapy.

H Ito1, T Imada, J Kondo, T Amano, T Maehara, Y Rino, M Takahashi, M Shiozawa, S Hatori, Y Suzuki.   

Abstract

A 71-year-old woman presented with an abdominal mass and ascites and was subsequently admitted to our hospital in June 1995. Further examination revealed that the mass was malignant and, as a result, surgery was indicated. However, the mass demonstrated widespread peritoneal dissemination, which therefore could not be resected, and pathological findings suggested a malignant peritoneal mesothelioma. The patient showed a remarkable response to combined chemotherapy with an accompanying intraperitoneal injection of cisplatin and etoposide and an intravenous injection of caffeine. However, owing to side effects, this regimen was discontinued. The patient was administered a combination drug of uracil and tegafur (UFT) in addition to intraperitoneal injection of cisplatin as an outpatient. By the 223rd day after surgery, the tumor mass and ascites had completely disappeared according to the CT. Hence chemotherapy was judged to have resulted in complete remission. Such a marked response to chemotherapy is rare in an advanced malignant peritoneal mesothelioma such as the present case. Eight months later, the tumor recurred in the pleura. Another regimen of chemotherapy with cisplatin and CPT-11 was performed. However, this treatment proved ineffective. The patient subsequently died of respiratory failure in January 1997 due to the mesothelioma. This is a case report of complete remission of malignant peritoneal mesothelioma by combined chemotherapy.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9544832     DOI: 10.1093/jjco/28.2.145

Source DB:  PubMed          Journal:  Jpn J Clin Oncol        ISSN: 0368-2811            Impact factor:   3.019


  3 in total

1.  Characterization of DNA hypermethylation in two cases of peritoneal mesothelioma.

Authors:  Ryota Hama; Yoshiyuki Watanabe; Kanako Shinada; Yosuke Yamada; Yuka Ogata; Yoshihito Yoshida; Tomohiro Tamura; Tetsuya Hiraishi; Ritsuko Oikawa; Jo Sakurai; Tadateru Maehata; Hirotaka Koizumi; Fumio Itoh
Journal:  Tumour Biol       Date:  2012-07-27

2.  Significant Clinical Benefit of Pemetrexed-based Chemotherapy for Advanced Diffuse Malignant Peritoneal Mesothelioma: A Case Presentation.

Authors:  Milena Peitl; Sven Seiwerth; Martina Bašić-Koretić; Fedor Šantek
Journal:  Indian J Med Paediatr Oncol       Date:  2017 Jan-Mar

Review 3.  Intracavitary therapies for mesothelioma.

Authors:  C F Verschraegen
Journal:  Curr Treat Options Oncol       Date:  2001-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.